BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25469245)

  • 41. Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis.
    Huang Z; Liu F
    Tumour Biol; 2014 Aug; 35(8):7459-65. PubMed ID: 24789274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Volumetric and morphological analysis of intraductal papillary mucinous neoplasm of the pancreas using computed tomography and magnetic resonance imaging.
    Murayama S; Kimura W; Hirai I; Takasu N; Takeshita A; Moriya T
    Pancreas; 2011 Aug; 40(6):876-82. PubMed ID: 21747312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathological features and medical management of intraductal papillary mucinous neoplasms.
    Okabayashi T; Kobayashi M; Nishimori I; Sugimoto T; Namikawa T; Okamoto K; Okamoto N; Kosaki T; Onishi S; Araki K
    J Gastroenterol Hepatol; 2006 Feb; 21(2):462-7. PubMed ID: 16509876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
    Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dermokine expression in intraductal papillary-mucinous neoplasm and invasive pancreatic carcinoma.
    Watanabe K; Oochiai T; Kikuchi S; Kumano T; Matsui T; Morimoto K; Yasukawa S; Nakamori S; Sasako M; Yanagisawa A; Otsuji E
    Anticancer Res; 2012 Oct; 32(10):4405-12. PubMed ID: 23060565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
    Zhu FL; Ling AS; Wei Q; Ma J; Lu G
    Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression.
    Roch AM; Ceppa EP; Al-Haddad MA; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Ann Surg; 2014 Oct; 260(4):680-8; discussion 688-90. PubMed ID: 25203885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
    Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
    Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and Potential Utility of a New Scoring Formula for Prediction of Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Suzuki Y; Nakazato T; Yokoyama M; Kogure M; Matsuki R; Abe N; Mori T; Ohkura Y; Sugiyama M
    Pancreas; 2016 Oct; 45(9):1227-32. PubMed ID: 27171512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the Fukuoka Consensus Guidelines for intraductal papillary mucinous neoplasms of the pancreas: Results from a systematic review of 1,382 surgically resected patients.
    Goh BK; Lin Z; Tan DM; Thng CH; Khor CJ; Lim TK; Ooi LL; Chung AY
    Surgery; 2015 Nov; 158(5):1192-202. PubMed ID: 26032832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of combined detection of CA72-4, CA19-9, and carcinoembryonic antigen comparing to CA72-4 alone in gastric cancer: a systematic review and meta-analysis.
    Wang H; Jin W; Wan C; Zhu C
    Transl Cancer Res; 2022 Apr; 11(4):848-856. PubMed ID: 35571668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.
    Simpson RE; Yip-Schneider MT; Flick KF; Wu H; Colgate CL; Schmidt CM
    Pancreas; 2019 Sep; 48(8):1026-1031. PubMed ID: 31404023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carcinoembryonic antigen levels in pancreatic juice are associated with histological subtypes of intraductal papillary mucinous neoplasm of the pancreas.
    Hayakawa H; Fukasawa M; Takano S; Shindo H; Takahashi E; Kawakami S; Fukasawa Y; Kuratomi N; Sato T; Kadokura M; Hirose S; Maekawa S; Inoue T; Yamaguchi T; Harai S; Kawaida H; Kono H; Mochizuki K; Enomoto N
    DEN Open; 2023 Apr; 3(1):e169. PubMed ID: 36247313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses.
    Li B; Li Q; Chen C; Guan Y; Liu S
    Acad Radiol; 2014 Jan; 21(1):21-9. PubMed ID: 24331261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
    Pedrazzoli S; Sperti C; Pasquali C; Bissoli S; Chierichetti F
    Ann Surg; 2011 Dec; 254(6):971-6. PubMed ID: 22076067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a new cryptococcal antigen lateral flow immunoassay in serum, cerebrospinal fluid and urine for the diagnosis of cryptococcosis: a meta-analysis and systematic review.
    Huang HR; Fan LC; Rajbanshi B; Xu JF
    PLoS One; 2015; 10(5):e0127117. PubMed ID: 25974018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.